Log in to save to my catalogue

Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: progn...

Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: progn...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037691

Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies

About this item

Full title

Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies

Publisher

Berlin: Springer

Journal title

Cancer Immunology, Immunotherapy, 1997-06, Vol.44 (4), p.211-215

Language

English

Formats

Publication information

Publisher

Berlin: Springer

More information

Scope and Contents

Contents

To investigate the clinical significance of the enhanced sensitivity of antibody detection by radio immunoprecipitation assays (RIPA), using in vitro translated HPV-16 E6 and E7 proteins, over synthetic-peptide enzyme-linked immunosorbent assay (ELISA), RIPA for HPV-16 E6 and E7 were performed. The results obtained with E6 and E7 RIPA were related...

Alternative Titles

Full title

Relation between HPV-16 serology and clinico-pathological data in cervical carcinoma patients: prognostic value of anti-E6 and/or anti-E7 antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037691

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037691

Other Identifiers

ISSN

0340-7004

E-ISSN

1432-0851

DOI

10.1007/s002620050375

How to access this item